{"id":5225,"date":"2019-05-28T14:45:17","date_gmt":"2019-05-28T12:45:17","guid":{"rendered":"http:\/\/www.seventure.fr\/?p=5225"},"modified":"2019-06-14T14:46:24","modified_gmt":"2019-06-14T12:46:24","slug":"european-venture-capital-firm-seventure-partners-renews-its-support-to-domain-therapeutics-and-invests-e3-5m-3-9m-to-prepare-the-next-growth-phase","status":"publish","type":"post","link":"https:\/\/www.seventure.fr\/en\/european-venture-capital-firm-seventure-partners-renews-its-support-to-domain-therapeutics-and-invests-e3-5m-3-9m-to-prepare-the-next-growth-phase\/","title":{"rendered":"European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests \u20ac3.5M ($3.9M) to prepare the next growth phase"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[101,106],"tags":[],"acf":[],"yoast_head":"\nEuropean Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests \u20ac3.5M ($3.9M) to prepare the next growth phase | Seventure<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seventure.fr\/seventure-partners-renouvelle-sa-confiance-dans-domain-therapeutics-en-realisant-un-nouvel-investissement-de-35me\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ra\u00efssa Brian\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.seventure.fr\/seventure-partners-renouvelle-sa-confiance-dans-domain-therapeutics-en-realisant-un-nouvel-investissement-de-35me\/\",\"url\":\"https:\/\/www.seventure.fr\/seventure-partners-renouvelle-sa-confiance-dans-domain-therapeutics-en-realisant-un-nouvel-investissement-de-35me\/\",\"name\":\"European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests \u20ac3.5M ($3.9M) to prepare the next growth phase | Seventure\",\"isPartOf\":{\"@id\":\"https:\/\/www.seventure.fr\/#website\"},\"datePublished\":\"2019-05-28T12:45:17+00:00\",\"dateModified\":\"2019-06-14T12:46:24+00:00\",\"author\":{\"@id\":\"https:\/\/www.seventure.fr\/#\/schema\/person\/6bb6ba61919ee7bed3cdfed85c80b7cc\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.seventure.fr\/seventure-partners-renouvelle-sa-confiance-dans-domain-therapeutics-en-realisant-un-nouvel-investissement-de-35me\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.seventure.fr\/seventure-partners-renouvelle-sa-confiance-dans-domain-therapeutics-en-realisant-un-nouvel-investissement-de-35me\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.seventure.fr\/seventure-partners-renouvelle-sa-confiance-dans-domain-therapeutics-en-realisant-un-nouvel-investissement-de-35me\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.seventure.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests \u20ac3.5M ($3.9M) to prepare the next growth phase\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.seventure.fr\/#website\",\"url\":\"https:\/\/www.seventure.fr\/\",\"name\":\"Seventure\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.seventure.fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.seventure.fr\/#\/schema\/person\/6bb6ba61919ee7bed3cdfed85c80b7cc\",\"name\":\"Ra\u00efssa Brian\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.seventure.fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/258549f10ce18eba5dfd8cf2ba1d953b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/258549f10ce18eba5dfd8cf2ba1d953b?s=96&d=mm&r=g\",\"caption\":\"Ra\u00efssa Brian\"},\"url\":\"https:\/\/www.seventure.fr\/en\/author\/raissa\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests \u20ac3.5M ($3.9M) to prepare the next growth phase | Seventure","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seventure.fr\/seventure-partners-renouvelle-sa-confiance-dans-domain-therapeutics-en-realisant-un-nouvel-investissement-de-35me\/","twitter_misc":{"Written by":"Ra\u00efssa Brian"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.seventure.fr\/seventure-partners-renouvelle-sa-confiance-dans-domain-therapeutics-en-realisant-un-nouvel-investissement-de-35me\/","url":"https:\/\/www.seventure.fr\/seventure-partners-renouvelle-sa-confiance-dans-domain-therapeutics-en-realisant-un-nouvel-investissement-de-35me\/","name":"European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests \u20ac3.5M ($3.9M) to prepare the next growth phase | Seventure","isPartOf":{"@id":"https:\/\/www.seventure.fr\/#website"},"datePublished":"2019-05-28T12:45:17+00:00","dateModified":"2019-06-14T12:46:24+00:00","author":{"@id":"https:\/\/www.seventure.fr\/#\/schema\/person\/6bb6ba61919ee7bed3cdfed85c80b7cc"},"breadcrumb":{"@id":"https:\/\/www.seventure.fr\/seventure-partners-renouvelle-sa-confiance-dans-domain-therapeutics-en-realisant-un-nouvel-investissement-de-35me\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seventure.fr\/seventure-partners-renouvelle-sa-confiance-dans-domain-therapeutics-en-realisant-un-nouvel-investissement-de-35me\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seventure.fr\/seventure-partners-renouvelle-sa-confiance-dans-domain-therapeutics-en-realisant-un-nouvel-investissement-de-35me\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.seventure.fr\/en\/"},{"@type":"ListItem","position":2,"name":"European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests \u20ac3.5M ($3.9M) to prepare the next growth phase"}]},{"@type":"WebSite","@id":"https:\/\/www.seventure.fr\/#website","url":"https:\/\/www.seventure.fr\/","name":"Seventure","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seventure.fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.seventure.fr\/#\/schema\/person\/6bb6ba61919ee7bed3cdfed85c80b7cc","name":"Ra\u00efssa Brian","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.seventure.fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/258549f10ce18eba5dfd8cf2ba1d953b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/258549f10ce18eba5dfd8cf2ba1d953b?s=96&d=mm&r=g","caption":"Ra\u00efssa Brian"},"url":"https:\/\/www.seventure.fr\/en\/author\/raissa\/"}]}},"_links":{"self":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts\/5225"}],"collection":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/comments?post=5225"}],"version-history":[{"count":1,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts\/5225\/revisions"}],"predecessor-version":[{"id":5229,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts\/5225\/revisions\/5229"}],"wp:attachment":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media?parent=5225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/categories?post=5225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/tags?post=5225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}